Held on 08 December 2017
The Board of Nath Bio-Genes (India) has approved increase in authorised share capital from Rs 17 crore to Rs 21 crore. The Board also approved raising of funds for an aggregate amount of Rs 160 crore by way of issue of securities. The Board decided to convene EGM on 05 January 2018.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
